A carregar...
The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors
The baculovirus expression vector system (BEVS) platform has become an established manufacturing platform for the production of viral vaccines and gene therapy vectors. Nine BEVS‐derived products have been approved – four for human use (Cervarix®, Provenge®, Glybera® and Flublok®) and five for veter...
Na minha lista:
| Publicado no: | Biotechnol J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
WILEY‐VCH Verlag
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7159335/ https://ncbi.nlm.nih.gov/pubmed/25800821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.201400438 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|